Singapore: Global Pharmaceutical company, AstraZeneca plans to integrate Dendrimer drug delivery technology developed by...
Singapore: Mundipharma, global pharmaceutical company with operations in Singapore, has entered into a license agreement...
Singapore: TNI BioTech and Hubei Qianjiang Pharmaceutical, a leading Chinese pharmaceutical company will co-develop new...
Singapore: Drug Discovery company, Evotec has inked a research collaboration and licensing deal with Swiss Pharma compan...
Singapore: Researchers from St Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with re...
Singapore: Agilent Technologies has introduced the Agilent Automated Card Extraction LC/MS system, a fully integrated in...
Singapore: AMRI has signed a definitive agreement to acquire all the outstanding shares of Cedarburg Pharmaceuticals for...
As a scientist-turned entrepreneur, my journey has taken a long time, with many struggles along the way. For an entrepre...
Singapore: US Food and Drug Administration (FDA) has approved Novartis' Xolair (omalizumab) for the treatment of chronic...
Singapore: The US Food and Drug Administration (FDA) has granted approval for PR610, an anticancer "stealth" drug invent...
Merck announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA (pembrolizumab)monotherapy, the c...
Singapore: AstraZeneca signed a memorandum of understanding (MoU) with the Korea Health Industry Development Institute (...
Singapore: U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug Application (sNDA), co-developed...
Singapore: Australia based Bionomics is recognized as the Innovative Asian Biotech of the Year at BioPharma Asia Industr...
Singapore: US-based Vertex Pharmaceuticals has received Therapeutic Goods Administration (TGA) of Australia approval of ...
Singapore: Singapore-based Austrianova presented additional safety and efficacy data from a second phase II pancreatic c...
Singapore: Genentech's omalizumab has shown success in reducing disease severity in patients with moderate to severe chr...
Singapore: Phylogica has been granted a new European patent (no. 1793841) entitled: 'Peptide inhibitors of c-Jun dimeriz...
